12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Express News | WW International Shares up 6.6% Premarket ; US FDA to Reconsider Decision Barring Compounded Versions of Lilly's Weight Loss Drug
Catalyst Watch: Netflix Earnings, Lenovo Tech Event, Paris Motor Show, and Eyes on Oil
U.S. stocks closed: The three major indices are "unconcerned" about the bearish data, Chinese concept stocks rebounded from the downturn.
①Both inflation and unemployment data exceeded expectations, causing a slight decline in the three major U.S. stock indexes; ② The Nasdaq China Golden Dragon Index stabilized and rebounded; ③ AMD released a competitor to Nvidia in the AI chip market, causing a drop in stock price; ④ A weight-loss platform offering a 'budget version GLP-1 medication' saw continuous stock price increase, with analysts warning of risks.
Express News | Barclays Maintains Underweight on WW International, Maintains $0.75 Price Target
WW International Analyst Ratings
72553206 : Damn, you’ve earned a follow my dude. I appreciate the heads up.
OptionsKing OP 72553206 : It's nice that it popped higher, but it's not going to save their business. model. Operah resigned a month back. Probably did not want her name on this moving forward
Bartholomew Harner : It's going back to $0.75 or lower because you don't need another middleman like WW to take their cut if you take the weight loss shots. These lawsuits are par for the course and just lawyers cashing in where they can. They won't even dent the profits of the manufacturers. These drugs are never leaving the market because anyone who can shell out a few hundred bucks is all but guaranteed to lose 30 lbs in a couple of months with little to no effort. Basically a miracle in a shot. They can have side effects, but fewer with Tirzepatide than with Semaglutide. I have yet to meet anyone who says the results weren't worth it.